Pumpkin Seed Oil for Benign Prostatic Hyperplasia

Verdict: Weak, marginal benefit for BPH symptoms

Pumpkin seed oil shows only weak, low-quality evidence for benign prostatic hyperplasia: the largest trial found a statistically significant but clinically trivial symptom improvement, and no major urological guideline recommends it. It is not an established treatment and should not replace proven therapies.

C 🟠 C Weak Evidence Published

🔬Why this grade7-layer evidence engine

The grade is Weak (C) because the human evidence is thin and the measured effect is small. The largest, best-designed trial, the double-blind GRANU study (PMID 25196580, n=1,431), found that whole pumpkin seed lowered the International Prostate Symptom Score by only about 1.1 points versus placebo over 12 months, below the roughly 3-point threshold usually considered clinically meaningful, and the pumpkin seed extract arm showed no benefit at all.

Supporting trials are weaker still. Hong 2009 (PMID 20098586) reported symptom relief from pumpkin seed oil comparable to saw palmetto, but it enrolled just 47 men, was open-label, and showed no change in prostate volume or PSA. The 2,245-patient Curbicin study (PMID 11025395) used a pumpkin-plus-saw-palmetto combination with no placebo control or blinding, so it cannot isolate any effect of the oil itself.

Authorities are unconvinced. The FDA takes no efficacy position, the EFSA rejected a related health claim for lack of established cause and effect, and major clinics (Mayo, Cleveland, Harvard) and the AUA guidelines are silent on pumpkin seed oil for BPH. The mechanism is plausible and side effects are minor, but the evidence does not support it as a reliable treatment.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.49
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
78%
Broadly consistent
Evidence level
E4
Multiple large RCTs (n≥500 each)

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L2 PubMedPrimary literature
0.60
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.488
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study
PMID: 25196580 2015 RCT (double-blind) n = 1,431
Finding: Pumpkin seed (whole seed) showed a statistically significant but modest IPSS reduction vs placebo at 12 months; pumpkin seed extract did not differ significantly from placebo; effect size small and clinical relevance uncertain.
Mixed funding Effect size: IPSS MD approx. -1.1 points vs placebo (whole seed arm); extract arm NS
View on PubMed
Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia (Hong et al.)
PMID: 20098586 2009 RCT (open-label) n = 47
Finding: Both pumpkin seed oil and saw palmetto oil reduced IPSS and improved QoL; combination did not provide additional benefit. Small sample, open-label design, no improvement in prostate volume or PSA.
🟠 Limited quality Academic Effect size: IPSS reduction approx. -7 to -8 points in active arms (within-group)
View on PubMed
[Prosta Fink Forte capsules in the treatment of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients]
PMID: 11025395 2000 RCT (open-label) n = 2,245
Finding: Reported improvement in micturition frequency, nocturia, and subjective symptoms; methodologically weak (no placebo control, no blinding, surveillance design).
🟠 Limited quality ⚠️ Industry-funded Effect size: Not reported as controlled effect size; descriptive improvements only
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
PUMPKIN SEED OIL — CAS Registry Number: 8016-49-7 — Regulatory Citation: 175.300 source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of a combination of thiamin, riboflavin, niacin, pantothenic acid, pyridoxine, D-biotin and pumpkin seed oil (Cucurbita pepo L.) and maintenance of normal hair source↗
L4d TW TFDA / 衛福部
Neutral
南瓜籽油(Cucurbita moschata Duchesne 種子榨取之油脂)列於可供食品使用之原料;健康食品可宣稱之保健功效共 13 項,未包含『攝護腺保健』或『改善下泌尿道症狀』。 source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-bph-INT-pumpkin-seed-oil-001 繁體中文版 →